Cost-Effectiveness Analysis of Adding Ivabradine to Current Standard Therapy Versus Standard Therapy Alone in Patients with Chronic Heart Failure in Japan
International Heart Journal · 2024
DOI: 10.1536/ihj.24-194 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Heart Journal, 2024. Verfasst von Takayuki Inomata und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences. Hauptthemen laut MEDLINE: Ivabradine, Heart Failure, Cost-Benefit Analysis, Quality-Adjusted Life Years. Die Arbeit nennt 22 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences.
- Policy Planning and Communications External Affairs, Corporate Planning Division, Ono Pharmaceutical Co. Ltd.
- Data Strategy & Planning, Digital Strategy & Planning Department, Ono Pharmaceutical Co. Ltd.
- Real World Evidence Solutions & HEOR, IQVIA Solutions Japan G.K.
- Department of Public Health, Yokohama City University School of Medicine.
- Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo.
Zitieren
APA
Inomata, T., Fukuda, T., Yamashita, N., Niibe, K., Demiya, S., Matsuda, H., & Igarashi, A. (2024). Cost-Effectiveness Analysis of Adding Ivabradine to Current Standard Therapy Versus Standard Therapy Alone in Patients with Chronic Heart Failure in Japan. International Heart Journal. https://doi.org/10.1536/ihj.24-194
Vancouver
Inomata T, Fukuda T, Yamashita N, Niibe K, Demiya S, Matsuda H, et al. Cost-Effectiveness Analysis of Adding Ivabradine to Current Standard Therapy Versus Standard Therapy Alone in Patients with Chronic Heart Failure in Japan. International Heart Journal. 2024. doi:10.1536/ihj.24-194
BibTeX
@article{Inomata2024,
author = {Inomata, Takayuki and Fukuda, Takeshi and Yamashita, Nobuya and Niibe, Koji and Demiya, Sven and Matsuda, Hiroyuki and Igarashi, Ataru},
title = {Cost-Effectiveness Analysis of Adding Ivabradine to Current Standard Therapy Versus Standard Therapy Alone in Patients with Chronic Heart Failure in Japan},
journal = {International Heart Journal},
year = {2024},
doi = {10.1536/ihj.24-194}
}
EUVIMED